by Bruce Sylvester – Researchers report that metformin therapy, a treatment for type 2 diabetes, could induce a lowering thyroid-stimulating hormone (TSH) in patients with underactive thyroids (hypothyroidism)…. read more.
by Bruce Sylvester – Following heart attack, patients who undergo revascularization of all significantly blocked arteries achieve better outcomes than patients who undergo revascularization of the “culprit” artery… read more.
by Bruce Sylvester – Researchers from first large randomized trial comparing paracetamol with placebo for lower back pain report that paracetamol did not excel placebo at hastening recovery… read more.
by Bruce Sylvester – Compared to no screening, flexible sigmoidoscopy screening has resulted in a reduced incidence of colorectal cancer and rate of death from colorectal cancer, researchers… read more.
by Bruce Sylvester – Researchers report that drug therapy for ADHD does not increase the risk of suicide attempts or suicide. The findings were published on June 18,… read more.
by Bruce Sylvester – Ibrutinib has significantly outperformed ofatumumab as a second-line therapy for chronic lymphocytic leukemia (CLL), according to a Phase 3 study published on May 31,… read more.
by Bruce Sylvester: After 13 months of high-dose statin therapy, STEMI (ST Segment Elevation Myocardial Infarction) patients achieved significant reductions in coronary atherosclerosis, researchers reported on Sept. 2,… read more.
by Bruce Sylvester: Two intravenous doses of an iron supplement appears to cause heart failure patients with iron deficiency to achieve significant improvements in functional capacity, quality of… read more.
Report from the ESC Annual Congress by Bruce Sylvester: The investigational monoclonal antibody alirocumab, which significantly lowers cholesterol on top of regular statin therapy, also lowers the incidence… read more.
Report from the European Society of Cardiology Annual Congress in Barcelona by Bruce Sylvester – Results from the PARADIGM-HF trial, presented at ESC 2014 on August 30,2014 and… read more.
by Bruce Sylvester – Ibrutinib has significantly outperformed ofatumumab as a second-line therapy for chronic lymphocytic leukemia (CLL), according to a Phase 3 study published on May 31,… read more.
by Bruce Sylvester: Fenofibrate treatment reduces cardiovascular disease risks in persons with type-2 diabetes, especially women, researchers reported on August 18 in Diabetologia.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
